|
|
|
Volumn 12, Issue 5, 1998, Pages 529-530
|
|
The impact of new antiretroviral regimes on HIV-associated hospital admissions and deaths [1]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
INDINAVIR;
LAMIVUDINE;
STAVUDINE;
COST EFFECTIVENESS ANALYSIS;
DEATH;
HEALTH CARE COST;
HOSPITAL ADMISSION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MAJOR CLINICAL STUDY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
VIRUS LOAD;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTI-HIV AGENTS;
FEMALE;
HIV INFECTIONS;
HIV-1;
HOSPITALIZATION;
HOSPITALS, TEACHING;
HOSPITALS, URBAN;
HUMANS;
MALE;
SEX DISTRIBUTION;
SPAIN;
|
|
EID: 0032568293
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (22)
|
|
References (7)
|
